Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (18007)	1/22/1999 9:43:00 AM
From: DaiS	Respond to of 23519

Vlad, John Dean: This may be he, >TI: The results of a 6 month multi-centre placebo controlled study of Invicorp in the treatment of non-psychogenic erectile dysfunction. AU: Hackett_G, Charig_C, Dean_J, Dinsmore_W, Gingell_C, Kell_P, Sandhu_D, Savage_D JN: JOURNAL OF UROLOGY, 1998, Vol.159, No.5 SS, p.918 IS: 0022-5347 DT: Meeting Abstract auanet.org I find no journal publications for this man. I am not saying that a doctor would prefentially prescribe viagra or muse or IC or whatever for financial gain. My hypothesis is simply that a doctor that has an initial failure with an ED treatment is more likely to be discouraged from using it in future. DaiS